Pasithea Therapeutics Corp. (KTTA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 9.07M |
| Enterprise Value | -46.09M |
| P/E Ratio | -0.2 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.07 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 1,958.94 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.41 |
| Return On Equity | -0.49 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -20.19M |
| Net Income | -20.43M |
| Diluted EPS | -2.91 |
Balance Sheet
| Total Cash | 45.66B |
| Total Cash/Share | 6,494.64 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 26.25 |
| Book Value Per Share | 7.09 |
Price History
| 52-Week Change | -34.96 |
| 52-Week High | 2.06 |
| 52-Week Low | 0.28 |
| Moving Average 50 Days | 0.5 |
| Moving Average 200 Days | 0.7 |
Statistics
| Average Volume | 247,422 |
| Shares Outstanding | 33.41M |
| % Held by Institutions | 238.76 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | January 02, 2024 |
AD
